RBC Capital Markets thinks CSL is a bargain at current levels. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool ...

Fireplace cleaning logs, sometimes called creosote-sweeping logs, are designed to reduce certain types of creosote buildup, the oily substance from wood, in your chimney. When burned, these logs ...

CSL Limited (OTCQX:CSLLY) (OTCQX:CMXHF), an Australian biotech focused on developing vaccines and blood-derived therapies, on Tuesday announced plans to invest approximately $1.5B in the U.S. over the ...

SYDNEY--Australia-based pharmaceutical company CSL plans to expand its U.S. production over the next five years as part of a $1.5 billion investment in the country. CSL, which produces plasma-derived ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company announced in August ...

CSL Ltd., the world’s second-biggest maker of flu shots, forecast a US vaccination rebound as health groups counter misinformation and rising illness rates revive concern about prevention. A recovery ...

CSL Seqirus, the vaccine unit of Australian biotech CSL, has signed a pact to provide Saudi Arabia with cell-based influenza shots and help establish its production in-country. The move forms part of ...

SYDNEY, Oct 28 (Reuters) - Australian biotech CSL (CSL.AX), opens new tab has cut its profit outlook and delayed plans to spin off its vaccine division, blaming an unprecedented fall in U.S. flu ...

Welcome to Wrinkles Week on the Strategist, where we’re deeply vetting skin-care solutions for anyone who’s looking to smooth fine lines and wrinkles (or prevent them showing up in the first place).

When cleaning hard floors, a broom is a standard tool of choice as it can be more convenient to use than a vacuum. However, brooms can require manual cleaning to prevent them from redepositing ...

CSL has moved quickly to spend some of the money freed up by recent cuts, securing an option to buy the phase 3-ready blood clotting specialist VarmX in return for $117 million upfront. Last month, ...

The S&P/ASX 200 closed 63.1 points lower, down 0.70%. Cue puns about CSL's (CSL) (-16.9%) share price performance vs blood letting, bloodbath, and any other bloody combination you can think of! 🚑 But ...